Form 8-K - Current report:
SEC Accession No. 0000950170-23-026166
Filing Date
2023-06-02
Accepted
2023-06-02 17:20:42
Documents
14
Period of Report
2023-05-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gern-20230531.htm   iXBRL 8-K 110373
2 EX-3.1 gern-ex3_1.htm EX-3.1 18345
3 EX-10.1 gern-ex10_1.htm EX-10.1 292314
  Complete submission text file 0000950170-23-026166.txt   586200

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gern-20230531_lab.xml EX-101.LAB 13897
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gern-20230531_pre.xml EX-101.PRE 11326
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gern-20230531.xsd EX-101.SCH 2367
8 EXTRACTED XBRL INSTANCE DOCUMENT gern-20230531_htm.xml XML 4879
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 23990211
SIC: 2834 Pharmaceutical Preparations